Dr. Lal Path Labs Ltd. has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Jun 28, 2025. Further, the company has informed the Exchange regarding voting results.
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal Path Labs held its 31st AGM on June 28, 2025, via video conferencing, where all 8 resolutions were passed with the required majority. Shareholders approved the audited financial statements for FY ended March 31, 2025 and declared a final dividend of Rs. 6 per equity share (face value Rs. 10). Re-appointments were cleared for Dr. Archana Lal Erdmann (retiring director), Mr. Rohit Bhasin as Independent Director for a second term of 5 years, and Mr. Arun Duggal as Independent Director for a second term of 3 years. A special resolution was also passed to pay remuneration to Non-Executive Director Mr. Rahul Sharma upon ESOP exercise, alongside appointments of secretarial and cost auditors. Voting turnout was strong at around 89.7% of outstanding shares, with nearly all resolutions getting 99-100% approval, and only a tiny fraction of dissenting votes (under 1%) on director re-appointments.
For shareholders, the final dividend of Rs. 6 per share is confirmed, and strong shareholder participation with overwhelming approval on all resolutions signals smooth governance with no major investor pushback.